SBRT in 3 Fractions for T1 Glottic Cancer

被引：0
|
作者：
Sanguineti, G. [1 ]
D'Urso, P. [2 ]
Bottero, M. [2 ]
Farneti, A. [2 ]
Giannarelli, D. [3 ]
Signori, A. [4 ]
Landoni, V. [5 ]
机构：
[1] IRCCS Regina Elena Natl Canc Inst, Dept Res & Adv Technol, Rome, Italy
[2] IRCCS Regina Elena Natl Canc Inst, Rome, Italy
[3] Fdn Policlin Univ Gemelli IRCCS, Rome, Italy
[4] Univ Genoa, Genoa, Italy
[5] IRCCS Regina Elena Natl Canc Inst, Lab Med Phys & Expert Syst, Rome, Italy
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
295
引用
收藏
页码：S100 / S100
页数：1
相关论文
共 50 条
  • [31] Hypo vs conventional radiotherapy for T1 glottic cancer: A prospective cohort study
    Salas, B.
    Dominguez Nuez, D. J.
    Cabrera, R.
    Ferrera, L.
    Lloret, M.
    Lara, P. C.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S644 - S644
  • [32] The impact of treatment time and smoking on local control and complications in T1 glottic cancer
    van der Voet, JCM
    Keus, RB
    Hart, AAM
    Hilgers, FJM
    Bartelink, H
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (02): : 247 - 255
  • [33] Does pretreatment hemoglobin level affect outcome in patients with T1 glottic cancer?
    Canaday, DJ
    Regine, WF
    Mohiuddin, M
    Zollinger, W
    Machtay, M
    Lee, J
    Schultz, D
    Rosenthal, DI
    Rudoltz, MS
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 308 - 308
  • [34] Effect of tumor bulk on local control and survival of patients with T1 glottic cancer
    Reddy, SP
    Mohideen, N
    Marra, S
    Marks, JE
    RADIOTHERAPY AND ONCOLOGY, 1998, 47 (02) : 161 - 166
  • [35] Intensity Modulated Radiation Therapy for T1 Glottic Cancer: Initial Clinical Outcomes
    Sevak, P. R.
    Awan, M. J.
    Gunn, G. B.
    Rosenthal, D. J.
    Fuller, C. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S454 - S454
  • [36] Clinical radiobiology of glottic T1 squamous cell carcinoma
    Skladowski, K
    Tarnawski, R
    Maciejewski, B
    Wygoda, A
    Slosarek, K
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (01): : 101 - 106
  • [37] EXCISIONAL BIOPSY IN THE SELECTIVE MANAGEMENT OF T1 GLOTTIC CANCER - A 3-YEAR FOLLOW-UP-STUDY
    BLAKESLEE, D
    VAUGHAN, CW
    SHAPSHAY, SM
    SIMPSON, GT
    STRONG, MS
    LARYNGOSCOPE, 1984, 94 (04): : 488 - 494
  • [38] Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience
    Gowda, RV
    Henk, JM
    Mais, KL
    Sykes, AJ
    Swindell, R
    Slevin, NJ
    RADIOTHERAPY AND ONCOLOGY, 2003, 68 (02) : 105 - 111
  • [39] TREATMENT OF T1 AND INSITU GLOTTIC CARCINOMA - THE TRANSORAL APPROACH
    VAUGHAN, CW
    STRONG, MS
    SHAPSHAY, SM
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 1980, 13 (03) : 509 - 513
  • [40] Outcomes of Carotid-Sparing IMRT for T1 Glottic Cancer: Comparison With Conventional Radiation
    Mohamed, Abdallah S. R.
    Smith, Blaine D.
    Smith, Joshua B.
    Sevak, Parag
    Malek, Jessica S.
    Kanwar, Aasheesh
    Browne, Theodora
    Gunn, G. Brandon
    Garden, Adam S.
    Frank, Steven J.
    Morrison, William H.
    Phan, Jack
    Zafereo, Mark
    Skinner, Heath
    Lai, Stephen Y.
    Hutcheson, Katherine A.
    Lewin, Jan S.
    Hessel, Amy E.
    Thekdi, Apurva A.
    Weber, Randal S.
    Fuller, Clifton D.
    Rosenthal, David I.
    LARYNGOSCOPE, 2020, 130 (01): : 146 - 153
12345